Tetrahydrocannabinol


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000014 Abnormalities, Drug-Induced PMID:29106691
MESH:D001008 Anxiety Disorders PMID:28093016; PMID:29750976; PMID:32209479; PMID:32725198; PMID:8788864
MESH:D001259 Ataxia PMID:27422357; PMID:32209479; PMID:32923660
MESH:D001714 Bipolar Disorder PMID:6295192
MESH:D001919 Bradycardia PMID:30002406; PMID:652837; PMID:885163; PMID:9190833
MESH:D001929 Brain Edema PMID:19782326
MESH:D002189 Marijuana Abuse PMID:18563365
MESH:D002375 Catalepsy PMID:10318961; PMID:11080195; PMID:12970091; PMID:18789920; PMID:19041390; PMID:2530142; PMID:27149200; PMID:27527584; PMID:27535976; PMID:28087785; PMID:28442584; PMID:28905207; PMID:30115766; PMID:3031535; PMID:31311288; PMID:31877572; PMID:32688070; PMID:32860777; PMID:8788864
MESH:D002972 Cleft Palate PMID:31690747
MESH:D003072 Cognition Disorders PMID:16510488; PMID:17578508; PMID:24776491; PMID:26826191; PMID:27422357; PMID:28220044; PMID:29982505; PMID:31982904
MESH:D003866 Depressive Disorder PMID:29982505; PMID:32725198
MESH:D004195 Disease Models, Animal PMID:23072421
MESH:D004211 Disseminated Intravascular Coagulation PMID:16161930
MESH:D004438 Ecchymosis PMID:16161930
MESH:D005317 Fetal Growth Retardation PMID:28578322; PMID:31953475
MESH:D006212 Hallucinations PMID:29748632
MESH:D006529 Hepatomegaly PMID:26884397
MESH:D006948 Hyperkinesis PMID:112635; PMID:6256790
MESH:D007022 Hypotension PMID:6257883; PMID:9190833
MESH:D007035 Hypothermia PMID:10318961; PMID:19041390; PMID:26361728; PMID:26799708; PMID:27149200; PMID:27527584; PMID:27535976; PMID:28442584; PMID:28592614; PMID:28846955; PMID:30965351; PMID:31029878; PMID:31110286; PMID:31524960; PMID:31877572; PMID:32385136; PMID:32688070; PMID:32860777; PMID:32923660; PMID:3666037; PMID:652837; PMID:9748483
MESH:D007859 Learning Disabilities PMID:12895676; PMID:15812570
MESH:D007970 Leukopenia PMID:30130528
MESH:D008569 Memory Disorders PMID:16406104; PMID:16510488; PMID:16936704; PMID:21767554; PMID:26799708; PMID:27422357; PMID:28093016; PMID:30610611
MESH:D009021 Morphine Dependence PMID:10727732; PMID:9734704
MESH:D009069 Movement Disorders PMID:10802025; PMID:15882845; PMID:16137723; PMID:9748483
MESH:D009139 Musculoskeletal Abnormalities PMID:30002406
MESH:D009293 Opioid-Related Disorders PMID:16823391
MESH:D009325 Nausea PMID:30195587
MESH:D009436 Neural Tube Defects PMID:19040278; PMID:31690747
MESH:D010554 Personality Disorders PMID:6324245
MESH:D010922 Placenta Diseases PMID:28578322
MESH:D010927 Placental Insufficiency PMID:31953475
MESH:D011041 Poisoning PMID:23494106
MESH:D011248 Pregnancy Complications PMID:16886060
MESH:D011297 Prenatal Exposure Delayed Effects PMID:10727732; PMID:12456917; PMID:17578508; PMID:21820648; PMID:26460022; PMID:26976041; PMID:30594692; PMID:31982904; PMID:36529297; PMID:7776847; PMID:8968950; PMID:9188039; PMID:9734704
MESH:D011605 Psychoses, Substance-Induced PMID:16612464; PMID:28220044; PMID:29982505
MESH:D011618 Psychotic Disorders PMID:27422357
MESH:D011654 Pulmonary Edema PMID:19782326
MESH:D011693 Purpura PMID:16161930
MESH:D011782 Quadriplegia PMID:16161930
MESH:D012164 Retinal Diseases PMID:31680560
MESH:D012206 Rhabdomyolysis PMID:16161930
MESH:D012559 Schizophrenia PMID:28648819
MESH:D012640 Seizures PMID:26460022; PMID:28874764; PMID:6268703; PMID:6299864; PMID:841172; PMID:982057
MESH:D013375 Substance Withdrawal Syndrome PMID:10727732; PMID:2560590; PMID:26937020
MESH:D013610 Tachycardia PMID:29689453; PMID:6257883; PMID:885163
MESH:D013617 Tachycardia, Supraventricular PMID:10587776
MESH:D015431 Weight Loss PMID:28093016; PMID:30130528
MESH:D015819 Substance Abuse, Intravenous PMID:26803499
MESH:D016142 Holoprosencephaly PMID:31690747
MESH:D018476 Hypokinesia PMID:26361728
MESH:D019465 Craniofacial Abnormalities PMID:31690747
MESH:D019954 Neurobehavioral Manifestations PMID:26976041
MESH:D019956 Stereotypic Movement Disorder PMID:9988095
MESH:D019957 Motor Skills Disorders PMID:26460022; PMID:32773031
MESH:D019966 Substance-Related Disorders PMID:21300050; PMID:26888056; PMID:28087785; PMID:30378732
MESH:D019970 Cocaine-Related Disorders PMID:31941717
MESH:D020567 Fetal Weight PMID:31690747
MESH:D020896 Hypovolemia PMID:16161930
MESH:D020964 Embryo Loss PMID:30002406
MESH:D049188 Prenatal Injuries PMID:31690747
MESH:D056912 Binge-Eating Disorder PMID:23072421
MESH:D058186 Acute Kidney Injury PMID:16161930
MESH:D059445 Anhedonia PMID:32725198
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:12813001

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.